Spirox

Spirox EBIT

The EBIT of Spirox (3055.TW) as of Sep 28, 2026 is -346.59 M TWD. In the previous year, EBIT was -291.00 M TWD — a change of 19.11% (lower).

EBIT

-346.59 MTWD

YoY

19.11%

Last updated:

In 2026, Spirox's EBIT was -346.59 M TWD, a 19.11% increase from the -291.00 M TWD EBIT recorded in the previous year.

The Spirox EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2018
66.23 M TWD
Jan 1, 2019
55.09 M TWD
Jan 1, 2020
21.45 M TWD
Jan 1, 2021
-324.67 M TWD
Jan 1, 2022
344.65 M TWD
Jan 1, 2023
-162.44 M TWD
Jan 1, 2024
-291.00 M TWD
Jan 1, 2025
-346.59 M TWD
The Spirox EBIT history
YEAREBITYoY
-346.59 MTWD+19.11%
-291.00 MTWD+79.14%
-162.44 MTWD-147.13%
344.65 MTWD-206.15%
-324.67 MTWD-1,613.55%
21.45 MTWD-61.06%
55.09 MTWD-16.82%
66.23 MTWD+22.57%
54.03 MTWD-68.51%
171.58 MTWD+110.46%
81.53 MTWD-72.72%
298.82 MTWD-506.86%
-73.45 MTWD-234.22%
54.72 MTWD-53.31%
117.20 MTWD-62.68%
314.04 MTWD+194.27%
106.72 MTWD-6.19%
113.75 MTWD-80.63%
587.41 MTWD+4.90%
559.96 MTWD—
Access this data via the Eulerpool API

Spirox Revenue

Spirox Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
3.15 B TWD
66.23 M TWD
86.17 M TWD
Jan 1, 2019
2.91 B TWD
55.09 M TWD
13.86 M TWD
Jan 1, 2020
3.70 B TWD
21.45 M TWD
-36.09 M TWD
Jan 1, 2021
2.65 B TWD
-324.67 M TWD
-358.98 M TWD
Jan 1, 2022
1.91 B TWD
344.65 M TWD
240.16 M TWD
Jan 1, 2023
1.34 B TWD
-162.44 M TWD
-56.09 M TWD
Jan 1, 2024
673.27 M TWD
-291.00 M TWD
-251.52 M TWD
Jan 1, 2025
459.21 M TWD
-346.59 M TWD
-302.97 M TWD

Spirox Margins

Spirox stock margins

The Spirox margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Spirox. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Spirox.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
22.36 %
2.10 %
2.73 %
Jan 1, 2019
18.77 %
1.89 %
0.48 %
Jan 1, 2020
14.80 %
0.58 %
-0.98 %
Jan 1, 2021
11.51 %
-12.27 %
-13.57 %
Jan 1, 2022
8.97 %
18.00 %
12.54 %
Jan 1, 2023
17.76 %
-12.10 %
-4.18 %
Jan 1, 2024
20.46 %
-43.22 %
-37.36 %
Jan 1, 2025
8.00 %
-75.48 %
-65.98 %

Spirox Stock analysis

What does Spirox do? The Spirox Corporation is a company that was founded in 2007 and is headquartered in Menlo Park, California. The company operates in the medical technology industry and specializes in the development of products for nasal breathing. The mission of Spirox is to help people who have difficulty breathing through their nose. The company has recognized that many people have difficulty breathing through their nose due to congestion or other issues. Breathing through the mouth, however, can lead to a range of health problems such as dry mouth, sleep apnea, and respiratory infections. Therefore, Spirox has set out to develop innovative solutions to facilitate nasal breathing. Spirox's products include both implantable and non-implantable solutions. The company has a small but effective product portfolio consisting of two products: the Latera Nasal Stent and the AeroForm Nasal Stent. The Latera Nasal Stent is used to permanently open the nasal passages and facilitate breathing. The placement of the stent is a minimally invasive procedure that is typically performed on an outpatient basis. The Latera Nasal Stent is inserted and secured in the nasal wings to allow for better airflow through the nostrils. The stent is made of polydioxanone (PDO), a biocompatible polymer fiber that is absorbed by the body. Spirox's second product, the AeroForm Nasal Stent, is a non-implantable nasal stent used for temporary relief of nasal breathing. The AeroForm is a soft stent made of a flexible polymer material. It is inserted into the nasal passages and forms a gentle expansion to facilitate nasal breathing. As a company, Spirox focuses on collaboration with specialists and clinics to ensure that their products have high success rates. The company has established a partnership with the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) to advance scientific research and development in the nasal breathing industry. Spirox is led by experienced executives from the medical technology industry. The CEO, Duke Rohlen, has over 20 years of experience in leading medical technology companies such as Inspire Medical Systems and CV Ingenuity. The board team also includes Elektra Papadopoulos as Chair of the Board, who has worked at Hologic and Boston Scientific, among others. Although Spirox is a relatively small company, it has already received several awards. In 2017, the company was awarded the Red Herring Top 100 North America Award, which recognizes companies that are leading in the innovation industry. Overall, Spirox is an emerging company in the medical technology industry that offers innovative solutions to facilitate nasal breathing. Through collaboration with doctors and clinics and a focus on scientific research, the company aims to improve the success and effectiveness of its products. Spirox is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Spirox's EBIT

Spirox's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Spirox's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Spirox's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Spirox’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Spirox stock

EBIT of Spirox is -346.59 M TWD in 2026.

EBIT of Spirox changed from -291.00 M TWD to -346.59 M TWD, representing a 19.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Spirox since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Spirox historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Spirox

All Key Metrics — Spirox